10:30 ET Clinical Chemistry Analyzers Market worth $20.86 billion by 2030 | MarketsandMarkets™
The clinical chemistry analyzers market is projected to grow from $25.92 billion in 2025 to $20.86 billion by 2030, at a CAGR of 5.6%. Growth is driven by rising chronic diseases, an aging population, and point-of-care testing. North America leads the market, with hospitals & clinics as the largest end-user segment. Lipid profile tests are expected to grow fastest due to obesity-related health issues. Major companies include Abbott Laboratories, Roche, and Siemens Healthineers.
, /PRNewswire/ -- According to MarketsandMarkets™, the clinical chemistry analyzers market is projected to grow from USD 25.92 billion in 2025 to USD 20.86 billion by 2030, at a CAGR of 5.6%.
Browse 270 market data Tables and 50 Figures spread through 235 Pages and in-depth TOC on "Clinical Chemistry Analyzers Market
Clinical Chemistry Analyzers Market Size & Forecast:
- Market Size Available for Years: 2023–2030
- 2025 Market Size: USD 25.92 billion
- 2030 Projected Market Size: USD 20.86 billion
- CAGR (2025–2030): 5.6%
Clinical Chemistry Analyzers Market Trends & Insights:
- The North America clinical chemistry analyzers market dominated in 2024.
- By product type, the reagents segment is expected to register the highest CAGR of 6.1%.
- By test type, the basic metabolic panels segment accounted for the largest share in 2024.
- By end user, the hospitals & clinics segment held the largest share in 2024.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144027310
The clinical chemistry analyzers market is witnessing steady growth, driven mainly by the rising prevalence of chronic and lifestyle-related diseases and an increasing elderly population. The growing adoption of point-of-care testing is further supporting market expansion, as these devices enable faster, more accessible, and convenient diagnostic solutions. Additionally, the ongoing modernization of healthcare infrastructure and the rising demand for efficient laboratory automation are creating new opportunities for market players, fostering innovation and improving overall diagnostic capabilities.
The hospitals & clinics segment accounted for the largest share of the clinical chemistry analyzers market, by end user segment, in 2024.
By end users, the clinical chemistry analyzers market is segmented into hospitals & clinics, diagnostic laboratories, research laboratories and institutes, and other end users. In 2024, hospitals & clinics accounted for the largest share of the market. This segment's growth is primarily driven by the increasing incidence of various diseases and disorders, the rising adoption of clinical chemistry analyzers in healthcare facilities, and ongoing technological advancements that enhance diagnostic efficiency and accuracy.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=144027310
The lipid profile tests segment is expected to register the highest growth rate during the forecast period.
The clinical chemistry analyzers market, segmented by test type, comprises basic metabolic panels, liver function panels, lipid profiles, renal function panels, thyroid function panels, electrolyte panels, and specialty chemical tests. The lipid profiles segment recorded the highest growth rate, mainly due to the increasing incidence of obesity and associated health complications such as cardiovascular diseases and metabolic disorders. Growing awareness of preventive healthcare and the importance of regular lipid monitoring has further contributed to the rising demand for lipid profile testing in clinical settings.
North America is the largest regional market for clinical chemistry analyzers.
The clinical chemistry analyzers market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest market share. This leading position is driven by factors such as a growing geriatric population, the rising prevalence of chronic and lifestyle-related diseases, supportive government initiatives, increased healthcare spending, well-developed healthcare infrastructure, and the availability of advanced diagnostic instruments.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144027310
Top Companies in Clinical Chemistry Analyzers Market:
The Top Companies in Clinical Chemistry Analyzers Market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), Hitachi, Ltd. (Japan), EKF Diagnostics Holdings plc (UK), and QuidelOrtho Corporation (US).
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Related Reports:
Life Science Instrumentation Market - Global Forecast to 2031
Veterinary Diagnostics Market - Global Forecast to 2030
Companion Animal Diagnostics Market - Global Forecast to 2029
Therapeutic Drug Monitoring Market - Global Forecast to 2029
In Vitro Diagnostics Market - Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
